Wikidata

(Q87416299)

English

Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression

scientific article published on 09 October 2012

In more languages

Statements

title
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23043283
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23043283%20AND%20SRC:MED&resulttype=core&format=json
retrieved
10 March 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q87416299&oldid=1248297997"